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The purpose of this study was to examine the effects of an exercise intervention on the total caloric intake (TCI) of breast cancer
patients undergoing treatment. A secondary purpose was to determine whether or not a relationship existed between changes
in TCI, body fat composition (%BF), and fatigue during the study, which lasted 6 months. Twenty females recently diagnosed with
breast cancer, scheduled to undergo chemotherapy or radiation, were assigned randomly to an experimental (N = 10) or control
group (N = 10). Outcome measures included TCI (3-day food diary), %BF (skinfolds), and fatigue (revised Piper Fatigue Scale).
Each exercise session was conducted as follows: initial cardiovascular activity (6-12 min), followed by stretching (5-10 min),
resistance training (15-30 min), and a cool-down (approximately 8 min). Significant changes in TCI were observed among groups
(F1,18 = 8.582; P = 0.009), at treatments 2 and 3, and at the end of the study [experimental (1973 ± 419), control (1488 ± 418);
experimental (1946 ± 437), control (1436 ± 429); experimental (2315 ± 455), control (1474 ± 294), respectively]. A significant
negative correlation was found (Spearman rho (18) = -0.759; P < 0.001) between TCI and %BF and between TCI and fatigue
levels (Spearman rho (18) = -0.541; P = 0.014) at the end of the study. In conclusion, the results of this study suggest that an
exercise intervention administered to breast cancer patients undergoing medical treatment may assist in the mitigation of some
treatment side effects, including decreased TCI, increased fatigue, and negative changes in body composition.
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Introduction
Breast cancer is the second leading cause of cancer-
related death among women. While breast cancer is ranked
third among the most common cancers present in society, it
is ranked fifth among overall cancer-related deaths (1). At
present, there are approximately 10.5 million Americans
with a cancer history and 2.4 million of those are breast
cancer survivors (2). An estimated 211,240 new cases of
invasive breast cancer were diagnosed among women in
the USA in 2005 (3). Modern technology advancements,
greater education, significant improvements in adjuvant che-
motherapies, and self-examinations have contributed to the
increased survival rate among breast cancer patients.
Reduced capacity for work and being less able to
efficiently complete tasks, both of which are often accom-
panied by weariness and tiredness, are conditions charac-
teristic of cancer-related fatigue (4). While the exact etiol-
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ogy of cancer-related fatigue is not fully understood, it is
thought to be based on the physiological and psychologi-
cal effects of cancer treatments. Regardless of treatment
type, the consistent and often persistent manifestation of
cancer treatment-related fatigue is pervasive.
There have been many theories concerning the factors
that contribute to cancer-related fatigue. One, for example,
suggests that a reduced blood count caused by chemo-
therapy could lead to anemia that results in fatigue (5,6).
Other factors include medications, psychological distress,
changes in immune function, excessive inactivity, neuro-
muscular dysfunction, and cognitive factors. The present
study, however, has focused attention on data that sug-
gest that the body’s inability to efficiently process nutrients,
notable changes in the body’s nutritional requirements
during and following treatment, and a decrease in overall
energy intake could be significant contributing factors to
the specific fatigue experienced by cancer patients under-
going treatment (7). Progressive weight loss and the rate at
which weight is lost during treatment have been associ-
ated with survivorship rates (8). In addition, negative
changes in body composition have been related to poor
responses to chemotherapy and an overall decrease in
quality of life (8).
Exercise has been shown to have a positive physi-
ological and psychological impact on mitigating some of
the side effects associated with treatment modalities, in-
cluding positive changes in body composition and fatigue
levels (1,7). Energy loss usually observed during treat-
ment has been shown to improve with an aerobic training
program (9). Results from studies that explored aerobic
and resistance training as the exercise modes showed
positive effects on decreasing fatigue levels, improvement
in quality of life, and muscle strength (7,8,10,11).
Even though the majority of studies involving aerobic
and resistance exercise have reported improvements in
aerobic capacity, muscle strength, body composition, and
fatigue (12,13), the impact of exercise on caloric intake,
usually known to be altered in patients undergoing treat-
ment, has not been fully explored. Furthermore, the rela-
tionship between changes in caloric intake, body composi-
tion, and fatigue levels has not been explored in previous
studies that involved exercise as a complementary therapy
aimed to assist in the mitigation of side effects of cancer
treatment. Therefore, the purpose of this study was to
examine the effects of an individualized prescriptive exer-
cise intervention on total caloric intake (TCI) in breast
cancer patients undergoing chemotherapy or radiation
treatment. A secondary purpose was to determine whether
or not a relationship existed between changes in TCI, body
composition, and fatigue during treatment.
Material and Methods
Subjects and experimental design
This is a randomized controlled trial study [experimen-
tal (exercise) and control (no exercise)] developed and
conducted in northern Colorado. TCI was assessed at six
intervals during the course of the study. Pre- (post-sur-
gery) and post-intervention (final assessment performed
at the end of the study) measures of cardiovascular endur-
ance, dynamic muscular endurance, body composition
(percent body fat, %BF), and fatigue levels were recorded
and included in the design.
Twenty female subjects with ages ranging from 35-70
years who had been recently diagnosed with having breast
cancer volunteered for this study. The following criteria
were used for determining whether or not an individual was
included in the study: a) recent breast cancer diagnosis; b)
designated to undergo any type of surgery; c) required to
receive either chemotherapy or radiation, or a combination
of the two after surgery; d) age between 35-70 years during
the course of the study. If cardiovascular disease, acute or
chronic respiratory disease, acute or chronic bone, joint, or
muscular abnormalities were observed during the medical
history review and physical examination by an oncologist,
and if it was determined that the volunteer would not be
able to engage in regular exercise, the patient was in-
formed and excluded from the study. Patient’s characteris-
tics are presented in Table 1.
After the screening process for participation and expla-
nations regarding the study, the study protocol was re-
viewed and participants decided if they wished to partici-
pate in the study. The protocol and an informed consent
form approved by the University of Northern Colorado’s
Internal Review Board (UNCO IRB) and the North Colo-
rado Medical Center’s Internal Review Board (NCMC IRB)
were signed by each participant. According the Health
Insurance Portability and Accountability Act of 1996
(HIPAA), all subjects recruited after April 13, 2003 were
asked to sign the HIPAA authorization to use or disclosure
protected health information for research prior to enroll-
ment in the study.
Table 1. Characteristics of breast cancer patients who partici-
pated in the study.
Control group Exercise group
Age (years) 56.6 ± 16 57.5 ± 23
Body weight (kg) 81.7 ± 25.0 77.3 ± 27.3
Height (cm) 169.2 ± 10.2 168.9 ± 10.2
Body fat (%) 29.84 ± 14.9 29.13 ± 10.1
Data are reported as means ± SD for 10 subjects in each group.
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Assessment protocols
Patients were assigned randomly to two different groups
the week after diagnosis and before surgery. Before sur-
gery, the patients were assessed for TCI, fatigue levels,
body composition (skinfolds) and fitness, which was com-
prised of cardiovascular endurance and dynamic muscu-
lar endurance tests. During the study, which lasted 6
months, TCI, body composition, and fatigue levels were
assessed 6 times throughout the investigation (pre-sur-
gery, post-surgery, at treatments 1, 2, 3, and at the end of
the study) and 2 fitness assessments were administered
(post-surgery, and at the end of the study). During treat-
ment, the assessments were performed at regular inter-
vals at approximately 4 weeks apart according to each
patient’s treatment schedule. Because some patients were
still receiving treatment during week 21, fitness assess-
ments were administered a day other than that of the
subject’s scheduled treatment. If a patient was to receive
only radiation, their treatment began at week 5, with their
first assessment being administered at week 6, followed by
weeks 10 and 14, and at the end of the study on the 21st
week. All patients were assessed at 4-week intervals
whether or not they began their treatment at week 5 as
mentioned previously.
Total caloric intake analysis
A 3-day food diary was used to record the amount of
caloric intake as determined by the recommendations of
the nutritional assessment guideline by Lee and Nieman
(14). The data were analyzed to determine whether TCI
had changed enough throughout the experiment to have
an effect on body composition. Patients were asked to
record both food and beverage consumption (including
snacks) for 2 days during the week and 1 day during the
weekend.
Body composition analysis
The body composition of each patient was assessed
using skinfold measurement for the determination of %BF.
Large skinfold calipers (Cambridge Scientific Industries,
Inc., USA) were used for the determination of body compo-
sition. Skinfold measurements were performed using the
3-site skinfold measurement formula for women (15). For
patients who had undergone transverse rectus abdominis
muscle flap reconstructive surgery, triceps, thigh and
suprailiac sites were used. The body composition assess-
ment was performed approximately 30 min prior to admin-
istration of cancer treatment by the oncologist.
Self-reported fatigue analysis
Fatigue levels were assessed using the revised Piper
et al. (16) Fatigue Scale (PFS). This 22-item self-reported
scale measures fatigue on a scale of 0 to 10, as well as 4
subjective fatigue domains: affective, sensory, cognitive,
and behavioral, yielding a total fatigue score. The majority
of cancer patients experience the highest levels of fatigue
approximately 3 days following treatment. Patients were,
therefore, asked to answer questions on the PFS during
the last day of the week before they reported to the next
scheduled assessment/treatment.
Fitness assessment
The assessment of cardiovascular endurance and dy-
namic muscular endurance were included in the fitness
assessments. Heart rate responses were determined by
each patient wearing a heart rate monitor throughout the
cardiovascular assessments and the control of intensity
during exercise sessions. Fitness assessments were per-
formed at the Rocky Mountain Cancer Rehabilitation Insti-
tute at the University of Northern Colorado (Greeley, CO,
USA). Cardiovascular endurance assessments were per-
formed on a Quinton model 65 treadmill (USA). Cardiovas-
cular endurance (VO2max) was assessed using the modi-
fied Bruce treadmill protocol. The test, which is a submaxi-
mal exercise test, is often used for high-risk populations
because of the low level of stress it imposes on patients
(17).
The following exercises were utilized to assess the
dynamic muscular endurance of each subject: leg exten-
sion, seated leg curl, lateral pull down, and seated chest
press. The assessments were performed on LifeFitness
(USA) and Quantum (USA) weight machines. A submaxi-
mal endurance protocol that required the use of free weights
helped predict one maximal repetition for each subject.
This submaximal endurance protocol was developed for
middle-aged and older women (18).
Exercise intervention
The exercise intervention assigned to the experimental
group began in week 6 of the study and lasted until the
conclusion of the study following week 21. The exercise
group began their routine approximately 3 weeks prior to
receiving their first cancer treatment due to the post-can-
cer surgery treatment schedule. Exercise sessions were
held at the Rocky Mountain Cancer Rehabilitation Institute
and/or at the University of Northern Colorado Campus
Recreation Center at no cost to the patient. Patients as-
signed to the experimental group exercised 2 days a week
for no longer than a 60-min period. The rest time allowed
between each session was no less than 48 h and no more
than 84 h. Each patient was assigned an individualized
exercise intervention program designed in accordance
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gested that while controlling energy intake, it may be
possible to increase energy expenditure through exercise
(21). Each exercise session was modified according to the
patient’s physical state prior to the exercise session. On
the days in which patients were experiencing extreme
fatigue the exercise session intensity and duration were
modified.
Statistical analysis
All data were analyzed using the statistical software
program SPSS, version 14.0, for Windows. Statistical sig-
nificance was determined with a probability value less than
or equal to 0.05. For the assessment of changes and
differences in TCI between the exercise and control groups,
a 2 x 6 mixed model repeated measures ANOVA was
used. TCI measurements used for the analyses included
measurements obtained prior to surgery, post-surgery,
during treatments 1, 2, 3, and at the end of the study (final
assessment). Tukey HSD post hoc analyses were per-
formed to determine at which time during treatment signifi-
cant differences between groups were observed. For the
correlation analyses relating TCI, %BF, and fatigue levels
in both the exercise and control groups during the study, a
Spearman rho correlation was employed. The variables
included in the model were the change score for TCI and
for %BF, and fatigue levels. The change in TCI, %BF, and
fatigue were determined as the difference between the
results of the final assessment compared to the initial
assessment.
Results
A significant time versus group interaction was present
(F4.346, 78.221 = 7.895; P < 0.001). In addition, the main effect
for group was significant (F1,18 = 8.582; P = 0.009) indicat-
ing that the exercise group (TCI = 1998.531 ± 451.65 kcal)
had a significantly higher TCI than our patients in the
control group (TCI = 1597.782 ± 359.08 kcal) (Figure 1).
The effect for time was marginally significant (F4.346, 78.221 =
2.084; P = 0.085).
After combining the exercise and control groups into
one, a relationship between TCI and %BF was explored.
A negative correlation was found (rho (18) = -0.759; P <
0.001), indicating a significant linear relationship between
the two variables. Patients with a greater change in TCI
(higher during final assessment compared to pre-surgery)
tended to have lower changes in %BF.
Using the same procedure, the relationship between
the change in TCI and fatigue level (PFS) was also ana-
lyzed using a Spearman rho correlation. A negative corre-
lation was found (rho (18) = -0.541; P = 0.014), indicating a
with the recommendations of the American College of
Sports Medicine exercise guidelines for elderly popula-
tions (19) and guidelines published in Exercise and Cancer
Recovery (20). Intensities varying from 40-60% of the
patient’s predicted maximum exercise capacity were as-
signed to each activity and were based on the results of the
first fitness assessment administered prior to surgery.
Each exercise session was supervised by an under-
graduate or graduate cancer exercise specialist from the
Department of Sport and Exercise Science, University of
Northern Colorado. The exercise training included cardio-
vascular, resistance, and flexibility training. Each exercise
session was conducted as follows: initial cardiovascular
activity (6-12 min), followed by a stretching session (5-10
min), resistance training (15-30 min), and a cool-down that
included stretching activities (approximately 8 min).
The intensities used for the resistance training program
were determined by the first fitness assessment (18). The
protocol was used to predict the highest level of intensity
for one maximum repetition during a sub-maximal endur-
ance test for middle- to older-aged women. All major muscle
groups were utilized during the resistance training ses-
sions. The exercises were performed using the LifeFitness
and Quantum weight machines, free weights, elastic bands,
or therapeutic balls. The resistance exercises were as
follows: lateral and front raises, triceps extension, leg
press, leg extension, leg curl, standing calf raises, horizon-
tal chest press, lateral pull down, alternating bicep curls
with dumbbells, regular crunches, oblique crunches, and
lower abdominal crunches.
Patients assigned to the exercise group increased the
number of sets performed each week, which never ex-
ceeded three sets of each exercise. During the first week,
subjects assigned to the experimental group had to endure
one set for each exercise performed during the sessions.
Subjects assigned to the exercise group progressively
increased to two then three sets per exercise by the end of
the study. Movements during each exercise were per-
formed at moderate speed (3 s of concentric phase and 3
s of the eccentric phase of the movement during each
repetition for each exercise). Rest time between each set
and each exercise varied according to the subject’s de-
sires, but was approximately 1 min.
Cardiovascular activities included the following: walk-
ing on a treadmill [Precor C966 (USA), Quinton 65, or
LifeFitness TR 9500 HR, the use of the cycle ergometer
(LifeFitness 8500 HR, or elliptical equipment LifeFitness
CT 9500 HR or Precor EFX 546). Exercise training pro-
grams have been shown to improve the overall quality of
life, level of fitness, improved levels of self-esteem, and
confidence of cancer patients (9). It has also been sug-
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significant relationship between TCI and fatigue. Patients
with a greater change in TCI tended to have greater
changes in fatigue level (fatigue level was lower during
final assessment than at pre-surgery).
Discussion
This study was designed to examine the impact of exer-
cise on TCI in breast cancer patients undergoing chemo-
therapy or radiation treatment. The results of the current
study suggest that an individualized prescriptive exercise
program including aerobic, flexibility, and resistance training
helps to increase breast cancer patient’s overall TCI while
receiving treatment. Patients placed in the exercise group
experienced an increase in TCI of 20% while the control
group experienced a decrease of approximately 7%. The
significant increase of TCI demonstrated by the exercise
group could be due to the impact of exercise on fatigue,
nausea, and the body’s physiological need for nourishment
following participation in physical activity.
The increased caloric intake experienced by the exer-
cise group may have contributed to the elevated energy
levels reported by patients in this group and thus reducing
the feeling of fatigue experienced prior to engaging in the
exercise regimen. Another finding of great importance was
the relationships observed between TCI and %BF. The
results of the current study are somewhat in agreement with
a study conducted by Winningham and MacVicar (22). They
examined the impact on nausea of a 10-week aerobic exer-
cise program administered three times per week. The popu-
lation included in the study was breast cancer patients
undergoing chemotherapy. A group of patients were ran-
domized to either an exercise (aerobic training), a placebo
(light flexibility workouts) or to a control non-exercise group.
Significant improvements were observed in the exercise
group but not in the placebo or control groups. These inves-
tigators concluded that the impact of aerobic exercise did, in
fact, reduce nausea in the aerobic exercise group and that
aerobic training could be safely implemented during treat-
ment. Since nausea is a common symptom experienced by
cancer patients during treatment, Winningham and Mac-
Vicar’s study showed that this type of exercise can reduce
symptoms of nausea during treatment. Even though the
current study did not assess nausea during treatment, it is
believed that the impact of the exercise intervention used in
the current study may have impacted nausea and conse-
quently allowed patients in the exercise group to experience
a higher caloric intake compared to the control group.
One of the major issues in the breast cancer population
is the increase in body weight during treatment. This in-
crease in body weight is usually followed by increased %BF
and reduced lean body mass. The increase in adiposity is
significantly associated with decrease survival and re-occur-
rence rates (23). Furthermore, in a large cohort study, Tretli
et al. (24) found that the association between obesity and
poor breast cancer outcome was of extreme importance. In
that study, women diagnosed with stage I breast cancer who
were in the upper quintile of body mass index were 70%
more likely to dye from breast cancer than those below this
level. Even though an increase in body weight usually oc-
curs during palliative care, during treatment, decreased TCI
can induce loss of lean tissue with increases in %BF that can
decrease overall functionality, tremendously affecting the
ability of patients to perform even the simple daily tasks. The
present study is the first that has explored the impact of
exercise on the relationship between TCI and body compo-
sition in breast cancer patients undergoing treatment.
The second purpose of this study was to determine the
extent of the relationship between TCI, body composition,
and fatigue throughout treatment. Our findings indicated that
breast cancer patients undergoing treatment who engage in
physical activity experience a higher caloric intake through-
out the duration of treatment than those who engage in little
to no physical activity while decreasing %BF and fatigue
levels compared to patients who do not engage in regular
physical activity. Galvao and Newton (1) reviewed many
studies that used exercise as an intervention to mitigate side
effects of cancer treatment and they found quite a few
studies in which body composition of patients in an exercise
group either maintained body weight and body composition
or improved body composition significantly.
Winningham et al. (25) conducted a study to determine
the effects of aerobic training on body composition in breast
Figure 1. Effect of exercise on total caloric intake of breast
cancer patients under treatment. The figure describes a period
of 24 weeks. *P ≤ 0.05 compared to control group (2 x 6 mixed
model repeated measures ANOVA).
714
Braz J Med Biol Res 41(8) 2008
C.L. Battaglini et al.
www.bjournal.com.br
cancer patients undergoing chemotherapy. Patients were
assigned to an exercise group that performed aerobic train-
ing for 10-12 weeks. The subjects exercised at a 60-80%
intensity of maximal heart rate. Using the skinfold measure-
ment, they reported increased lean body mass and de-
creased fat tissue for the subjects who exercised. Similarly,
the present study found improvement in body composition.
The major difference with the Winningham study was that an
exercise intervention composed of aerobic, resistance train-
ing, and flexibility was used in the current study.
Studies examining the impact of exercise on fatigue
levels of breast cancer patients have also shown great
improvement compared to baseline results or control
groups. In three studies conducted by Schwartz and col-
leagues (26-28), breast cancer patients engaged in 4
weeks of aerobic training consisting of walking showed a
significant decrease in overall fatigue levels. Mock et al.
(29) using a similar but longer duration protocol (5-6 weeks)
also found significant reduction of fatigue levels. A study
conducted by Segal et al. (30) using a protocol consisting
of resistance training as the primary form of exercise and a
prostate cancer population also found a significant de-
crease in overall fatigue levels. The current study used a
combination of aerobic, resistance, and flexibility workouts
as the intervention. In agreement with the studies cited
above, a significant reduction in fatigue levels was also
observed in the exercise group but not in the control group.
Besides confirming similar results described in the litera-
ture, the present study also detected a significant relation-
ship between both %BF and fatigue levels and TCI. The
improvement in body composition and the relationship be-
tween %BF and TCI was a great surprise. Although overall
body weight was maintained in the exercise group through-
out the experiment, the resulting decrease in %BF indicated
the significance of exercise intervention in promoting lean
body mass. This correlation suggests that exercise pro-
grams performed in conjunction with cancer patients under-
going treatment in this study were sufficient to cause a
positive change in body composition regardless of the in-
crease in TCI. Breast cancer patients undergoing treatment
are known to either gain or lose weight, sometimes resulting
in obesity or cancer-mediated cachexia. The reduction in
%BF while maintaining body weight observed as a result of
the exercise program administered throughout the current
study are positive indicators of the impact of exercise on
cancer patients while receiving treatment and should be
further explored. If the results of the current study can be
reproduced in a larger trial, exercise may turn into a powerful
intervention to assist patients to maintain or improve their
body weight/body composition, creating opportunities for
better treatment outcomes and improvement in survival.
Fatigue experienced by cancer patients has been de-
scribed as a process in which both psychological and physi-
ological changes during and after the administration of can-
cer treatments lead patients to experience a decrease in
their overall functionality (9). There was a significant inverse
relationship observed in the current study demonstrating an
increase in TCI paired with a reduction in fatigue levels in
patients assigned to the exercise group. The development of
fatigue in breast cancer patients is believed to be caused by
numerous factors. The results of the current study, however,
suggest that TCI becomes an important factor in managing
fatigue levels throughout treatment and therefore further
investigations on caloric intake during treatment for breast
cancer patients should be explored.
Since weight changes are usually associated with poor
diagnosis and treatment outcomes with adverse effects
being associated with the risk for the development of cardio-
vascular disease and diabetes, and for breast cancer recur-
rence, and to increase chances for long-term survival, exer-
cise seems to be a powerful and safe intervention for breast
cancer patients. Breast cancer survivors should be advised
to engage in healthy lifestyles to maintain healthy weight.
Even if body weight cannot be maintained to a recom-
mended level, research has shown that as little as 5-10%
reduction in a period of 6-12 months is sufficient to elicit
positive physiological changes, i.e., changes in elevated
plasma lipids and high fasting levels of insulin (31). Breast
cancer patients should be encouraged to maintain or even
increase their body weight during treatment. After treatment,
the maintenance of weight or safe weight reduction through
exercise and healthy diet should be encouraged for those
breast cancer survivors who gained more weight than ex-
pected. Moderate exercise, during and after treatment should
be considered for the maintenance of lean muscle mass
while avoiding excess body fat (32).
The results of this study suggest that the administration
of exercise as treatment in breast cancer patients receiving
chemotherapy may assist in the management of some side
effects, including a decrease in TCI, increased fatigue lev-
els, and negative changes in body composition. Therefore, it
is recommended that an individualized exercise prescription
composed of aerobic, resistance, and flexibility training be
suggested as a form of adjunct therapy to cancer treatment
to improve TCI, decrease fatigue levels, while also impacting
positively changes in body composition and fatigue levels
among breast cancer patients undergoing treatment.
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